Cell-growth and migration inhibition of human mesothelioma cells induced by 3-O-Methylfunicone from Penicillium pinophilum and cisplatin

被引:15
作者
Buommino, Elisabetta [1 ]
De Filippis, Anna [1 ]
Nicoletti, Rosario [2 ]
Menegozzo, Massimo [3 ]
Menegozzo, Simona [3 ]
Ciavatta, Maria Letizia [4 ]
Rizzo, Antonietta [1 ]
Brancato, Virginia [1 ]
Tufano, Maria Antonietta [1 ]
Donnarumma, Giovanna [1 ]
机构
[1] Univ Naples 2, Sect Microbiol & Clin Microbiol, Dept Expt Med, I-80128 Naples, Italy
[2] Council Res & Experimentat Agr, CAT Res Unit, Scafati, Italy
[3] SUN, Sect Job Med, Dept Expt Med, Naples, Italy
[4] Inst Biomol Chem ICB CNR, Pozzuoli, Italy
关键词
Mesothelioma; 3-O-methylfunicone; Cisplatin; Integrins; Metalloproteinase; Migration; MALIGNANT PLEURAL MESOTHELIOMA; MOLECULAR-BIOLOGY; METABOLITE; APOPTOSIS; CHEMOTHERAPY; EXPRESSION; MOTILITY;
D O I
10.1007/s10637-011-9698-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Malignant pleural mesothelioma is a fatal malignancy linked to asbestos exposure. The main challenge for mesothelioma treatment is to go beyond the drug resistance, in particular against cisplatin (CDDP), one of the most used chemotherapeutic drug. 3-O-methylfunicone (OMF) is a metabolite produced by the fungus Penicillium pinophilum; its antiproliferative properties have been previously studied in vitro. Particularly, OMF is able to inhibit mesothelioma cell motility. To improve the effects of CDDP by-passing the resistance of mesothelioma cells to this drug, in the present study we investigated the combined treatment of OMF with CDDP respectively in an established mesothelioma cell line (NCI) and primary mesothelioma cells (Mest). As compared to the effect of single treatments, the combination of OMF and CDDP resulted in a stronger inhibition of NCI and Mest cell proliferation. OMF combination with CDDP was also able to affect the migratory ability of NCI and Mest cells by down-regulating alpha v and beta 5 expression and reducing metalloproteinase 2 (MMP-2) production. In addition, this association was effective in modulating VEGF gene expression. This finding highlights the possibility to use OMF and CDDP together to regulate angiogenesis and tumour progression in mesothelioma.
引用
收藏
页码:1343 / 1351
页数:9
相关论文
共 27 条
[1]   3-O-methylfunicone, a metabolite of Penicillium pinophilum, inhibits proliferation of human melanoma cells by causing G2 + M arrest and inducing apoptosis [J].
Baroni, A. ;
De Luca, A. ;
De Filippis, A. ;
Petrazzuolo, M. ;
Manente, L. ;
Nicoletti, R. ;
Tufano, M. A. ;
Buommino, E. .
CELL PROLIFERATION, 2009, 42 (04) :541-553
[2]  
Bertolini F, 2003, CANCER RES, V63, P4342
[3]   3-O-Methylfunicone, a secondary metabolite produced by Penicillium pinophilum, induces growth arrest and apoptosis in HeLa cells [J].
Buommino, E ;
Nicoletti, R ;
Gaeta, GM ;
Orlando, M ;
Ciavatta, ML ;
Baroni, A ;
Tufano, MA .
CELL PROLIFERATION, 2004, 37 (06) :413-426
[4]   3-O-Methylfunicone, a metabolite produced by Penicillium pinophilum, modulates ERK1/2 activity, affecting cell motility of human mesothelioma cells [J].
Buommino, E. ;
Paoletti, I. ;
De Filippis, A. ;
Nicoletti, R. ;
Ciavatta, M. L. ;
Menegozzo, S. ;
Menegozzo, M. ;
Tufano, M. A. .
CELL PROLIFERATION, 2010, 43 (02) :114-123
[5]   3-O-methylfunicone produced by Penicillum pinophilum affects cell motility of breast cancer cells, downregulating αvβ5 integrin and inhibiting metalloproteinase-9 secretion [J].
Buommino, Elisabetta ;
Boccellino, Mariarosaria ;
De Filippis, Anna ;
Petrazzuolo, Marcella ;
Cozza, Valentina ;
Nicoletti, Rosario ;
Ciavatta, Maria Letizia ;
Quagliuolo, Lucio ;
Tufano, Maria Antonietta .
MOLECULAR CARCINOGENESIS, 2007, 46 (11) :930-940
[6]   The anti-tumour effect of low-dose continuous chemotherapy may partly be mediated by thrombospondin [J].
Damber, JE ;
Vallbo, C ;
Albertsson, P ;
Lennernäs, B ;
Norrby, K .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (03) :354-360
[7]   3-o-methylfunicone, a fungitoxic metabolite produced by the fungus Penicillium pinophilum [J].
De Stefano, S ;
Nicoletti, R ;
Milone, A ;
Zambardino, S .
PHYTOCHEMISTRY, 1999, 52 (08) :1399-1401
[8]   The Investigation of Effects of Quercetin and Its Combination with Cisplatin on Malignant Mesothelioma Cells In Vitro [J].
Demiroglu-Zergeroglu, A. ;
Basara-Cigerim, B. ;
Kilic, E. ;
Yanikkaya-Demirel, G. .
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2010,
[9]   Late cutaneous metastases to the face from malignant pleural mesothelioma: A case report and review of the literature [J].
Elbahaie, Alaaeldeen M. ;
Kamel, Dia E. ;
Lawrence, Julia ;
Davidson, Neville G. .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2009, 7 :84
[10]   Advances in the systemic therapy of malignant pleural mesothelioma [J].
Fennell, Dean A. ;
Gaudino, Giovanni ;
O'Byrne, Kenneth J. ;
Mutti, Luciano ;
van Meerbeeck, Jan .
NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (03) :136-147